Fast-Growing UK Network Life Science Platform Company, Eagle Genomics, Opens Indian Hub as World Interest in Microbiome Research Intensifies

Copyright 2021 PR Newswire. All Rights Reserved

The British success story continues apace as the most important names in meals, cosmetics, private care & agritech globally look to verify the optimistic organic affect of next-generation merchandise, and play their half in fixing real-world challenges capitalising on the worldwide microbiome megatrend

CAMBRIDGE, England, May 4, 2021 /PRNewswire/ — Eagle Genomics, a British pioneer in making use of community science to biology, has introduced the opening of a proper new operation in India – throughout the innovation hub of Laxmi Cyber City in Hyderabad – because the bio revolution continues to remodel the worldwide economic system.



Eagle Genomics has been hitting the headlines over the past 12 months, with its ground-breaking strategy to networking microbiome science – with its e[datascientist]™ information discovery platform – to assist deal with the world’s grand challenges together with a safe and sustainable future for our meals, water, soil, well being and the planet.

The on-the-ground growth into Hyderabad, the capital of southern India’s Telangana state and a serious centre for the know-how and biotechnology industries (India’s Genome Valley is shut), marks the newest milestone in Eagle Genomics’ customer-driven growth. The profitable and fast-growing British scale-up firm, whose revenues have soared by 300 per cent over the past 12 months, sees India as a essential base as a part of its continued worldwide growth. The firm, which is able to quickly launch a serious new funding spherical, already has a hub in New York’s Genome Center and additional bases in Paris and Berlin.

Eagle Genomics already had a staff of round 20 engineers working in Hyderabad, India, however the staff will now be very considerably expanded with its personal model new workplace area within the prestigious Laxmi Cyber City innovation hub.

UK Prime Minister Boris Johnson mentioned, “I’m delighted that Eagle Genomics is expanding into India to make the most of the opportunities for UK businesses in one of the world’s biggest economies. Our exporters are brilliant ambassadors for Britain, and I hope today’s announcement is just the start of what you can do for India and the UK.”

“The buildout of both the engineering and science teams in Hyderabad has already had a significant impact on Eagle Genomics’ growth,” commented Anthony Finbow, Eagle Genomics’ CEO. “We have been able to hire highly skilled, talented engineers in quantities and at a speed that we would not have been able to achieve had we sought to hire in the UK alone. This increased capacity, which will also lead to more hires in the UK to serve the vast Indian opportunity, is already positively impacting the cadence of our platform development, which opens up additional customer verticals and directly leads to growth in terms of customers won and the access to our most proximate addressable markets.”

Eagle Genomics can be forging strategic relationships with among the main scientific institutions in India centered on the microbiome, simply because it has executed in different markets most notably the UK, the place the corporate has helped form the Microbiome Strategic Roadmap. Eagle Genomics plans to be on the forefront of the Bio Revolution and sees microbiome science as the important thing to unlocking its potential.

Deepak Bagla, CEO of Invest India, added, “We are delighted to support Eagle Genomics on its India expansion plans. Eagle Genomics has made the right decision: to expand cutting-edge emerging technology innovation by partnering with India. Collaboration between UK and Indian organisations – with our ability to build world-class innovation and businesses together – is a recipe for truly global competitiveness.”

India’s curiosity within the microbiome is rising rapidly. To date, organisations together with ICAR: the Indian Council of Agricultural Research; ICRISAT: The International Crops Research Institute for the Semi-Arid Tropics; ICMR: The Indian Council of Medical Research (ICMR); Bangalore Life Science Cluster (BLiSC); and DBT: The Department of Biotechnology are rising their analysis into the position of the microbiome on crop development, inhabitants well being, environmental sustainability, and extra.

Eagle Genomics, which turned its focus to the microbiome in 2018, will drive additional growth with a brand new spherical of funding deliberate for the second half of this 12 months. Current Investors embody Environmental Technologies Fund (ETF) and a consortium of buyers from throughout science, AI and analytics fields led by Granpool Innovative Investments. Global revenues have grown by 300 per cent 12 months on 12 months over the latest 12-month interval.

Eagle Genomics’ spectacular observe document is right down to the corporate’s distinctive microbiome community science, which it’s placing within the fingers of business R&D groups with its e[datascientist] platform. Its international prospects embody the likes of Unilever and Cargill, manufacturers which have understood the substantial position of microbes in sustaining well being and wellbeing and selling renewal of the pure setting.

About Eagle Genomics

Eagle Genomics, headquartered in Cambridge, UK, innovates on the intersection of biology, knowledge sciences and bioinformatics. The firm specialises in delivering highly effective enterprise platform options for innovation within the microbiomics and genomics period. Its award-winning[1] AI-augmented information discovery platform, e[datascientist]™, helps firms conduct science led innovation for next-generation meals, private care, cosmetics and agritech merchandise. The platform harnesses causal community science, and superior machine studying and cognitive companies.

Eagle Genomics was based in 2008 with a deal with human DNA discovery in biotech and pharma, earlier than relaunching virtually a decade later with a brand new mission – to use community science to microbiome-related discovery. In 2018 it turned Microsoft Genomics’ first microbiome accomplice. Today the fast-growing international enterprise has operations on this planet’s main centres for genomics and AI. These embody Cambridge’s Wellcome BioInformation Innovation Centre and London’s Knowledge Quarter within the UK; Microsoft’s AI Factory in Paris; Potsdam Science Park; JLABS in New York, and the brand new facility in Laxmi Cyber City in Hyderabad, India.

Eagle Genomics works with 5 of the highest 10 family and private care firms on this planet to create and launch new merchandise which work in concord with the human and ecological microbiome. Find out extra at


Press contact for Eagle Genomics
Carina Birt, Sarum PR
+44 (0)797-000-6624

[1] BioIT World ‘Best of Show’; Hello Tomorrow Top 500 Deeptech Startup, Microsoft AI Factory, EIT Food Rising Star, WBCSD FReSH Gamechanger


Please enter your comment!
Please enter your name here